NCT07713940 Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous
| NCT ID | NCT07713940 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Diego |
| Condition | Systemic Lupus Erthematosus (SLE) |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2028-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2026-07-01 with a primary completion date of 2028-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To study the effect of anti-inflammatory diet on clinical and biological outcomes in lupus
Eligibility Criteria
Inclusion Criteria: * patients who meet the 2019 EULAR/ACR Classification Criteria for SLE * patients who are on Cellcept or Myfortic for at least 3 months prior to screening * patients with a score of ≥55 on the Patient Reported Outcomes Measurement Information System (PROMIS) Pain interference scale. Exclusion Criteria: * pregnant or lactating patients, * patients with food allergy * patients on antibiotics within 4 weeks of the screening * patients that change the SLE therapy during the length of the study (12 weeks).
Contact & Investigator
Monica Guma, MD, PhD
PRINCIPAL INVESTIGATOR
UC San Diego
Frequently Asked Questions
Who can join the NCT07713940 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Systemic Lupus Erthematosus (SLE). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07713940 currently recruiting?
Yes, NCT07713940 is actively recruiting participants. Contact the research team at mguma@health.ucsd.edu for enrollment information.
Where is the NCT07713940 trial being conducted?
This trial is being conducted at La Jolla, United States.
Who is sponsoring the NCT07713940 clinical trial?
NCT07713940 is sponsored by University of California, San Diego. The principal investigator is Monica Guma, MD, PhD at UC San Diego. The trial plans to enroll 36 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.